Breaks Categories: News

ThursdayAug 02, 2018 10:00 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Posts Record Date for Spinout Transaction

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTC: TGODF) this morning issued an update regarding its previously announced spinout transaction. The company will distribute a warrant in the new corporation, TGOD Acquisitions, to TGOD shareholders. Each warrant permits the holder to purchase a unit of TGOD Acquisitions at a price of $0.50 for a period of 30 days from completion of the spinout. Each unit is comprised of one common share and one additional warrant of TGOD Acquisitions. The record date for distribution of the warrants is anticipated to be on or about September 28,…

Continue Reading

ThursdayAug 02, 2018 9:48 am

CannabisNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Adds Third Entry to Lineup of Cannabis Brands

Leading Canadian cannabis company ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced the launch of Lumina, an adult-use cannabis brand and product line designed with health and wellness in mind. Per the update, Lumina supports a holistic approach to mental and physical well-being, which ABcann highlights as a key consideration in the flourishing wellness sector. “Lumina is the third entry in ABcann’s growing lineup of cannabis brands, joining Beacon Medical and FIRESIDE in our premium portfolio,” Barry Fishman, CEO of ABcann, stated in the news release. “Our extensive experience growing premium cannabis, emphasis on quality, and dedication to…

Continue Reading

ThursdayAug 02, 2018 9:23 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Enters Exclusive Co-marketing and Distribution Agreement

Pivot Pharmaceuticals (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has entered into a definitive co-marketing and distribution agreement with S.T.U. GmbH. The Switzerland-based company manufactures and markets "Hemplix™" brand CBD oils. Per the terms of the agreement, Pivot's proprietary cannabinoid-derived products will be marketed and sold by S.T.U. online and in retail stores, where regulations permit, in the U.K., Switzerland, Germany, Austria and Italy. Pivot will distribute the Hemplix™ product line where regulations permit, and upon receiving required licenses from regulatory authorities, in Canada, Latin America and the United States. "As we continue to execute on…

Continue Reading

WednesdayAug 01, 2018 10:01 am

CannabisNewsBreaks – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Inks Exclusive National Agreement with Natural Specialty Sales

Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF) this morning announced that it has signed an exclusive national agreement with Natural Specialty Sales (“NSS”), an Acosta company. NSS is well known in the natural/specialty market with a retail channel across America, providing Phivida access to over 2,400 retail locations in a $4.1 billion market. The national network includes major retailers including Whole Foods Market, Sprouts Farmers Market, and National Coop Grocers. The company’s OKI brand of premium CBD products, anticipated to launch in Q3 2018, will be the exclusive CBD-infused beverage brand and health supplements products represented by NSS. "There is no…

Continue Reading

WednesdayAug 01, 2018 9:30 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Reports Encouraging Bioavailability Results from TurboCBD™ Study

Drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) this morning reported noteworthy bioavailability results from its randomized, placebo-controlled, double-blind European human clinical study that evaluated TurboCBD™. TurboCBD™ is a proprietary, DehydraTECH™ powered, cannabidiol ("CBD") fortified hemp oil capsule developed by Lexaria. The study evaluated the degree and speed of CBD absorption into blood plasma and potential cardiovascular and cognitive performance enhancement in 12 healthy male volunteers. The study compared the 90 mg dose of Lexaria's TurboCBD™ to a 90 mg dose of a positive control formulation without Lexaria's DehydraTECH™ technology. Per the report, Lexaria's TurboCBD™ capsules continued to…

Continue Reading

TuesdayJul 31, 2018 1:33 pm

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Posts Update on Scorpion Venom-Derived Peptide Program

PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) today issued an update regarding the second phase of its three phase, scorpion venom-derived peptide research and development program. The program consists of identifying, extracting and sequencing peptides and proteins isolated from Caribbean Blue Scorpion venom. The goal of the program is to empower PreveCeutical to produce Nature Identical™ peptide therapeutics to treat, regulate and prevent cancer progression. The company’s initial focus will target glioblastoma, a highly-aggressive form of brain cancer. PreveCeutical has started phase 2 of the program, comprised of re-designing the peptides to enhance their biostability while upholding their potency…

Continue Reading

TuesdayJul 31, 2018 11:06 am

CannabisNewsBreaks – Marijuana Company of America Inc. (MCOA) and Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG) Issue Update on CBD Farming Project in Scio, Oregon

Marijuana Company of America (OTC: MCOA) and its joint venture (“JV”) partner Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG) provided an update this morning on their CBD hemp farming project in Scio, Oregon. The 2018 hemp cultivation at the farm, operating under the name Covered Bridge Acres (“CBA”), is ongoing. Approximately 40,000 high CBD yielding hemp plants have been planted on the lower two fields of the farm, on approximately 33 acres. Six different high CBD yielding hemp cultivars were planted this year, half of which were planted as clones and the other half were grown from…

Continue Reading

TuesdayJul 31, 2018 10:31 am

CannabisNewsBreaks – Global Payout, Inc. (GOHE) Welcomes Stormy Simon as Strategy Officer and Board Member

Global Payout, Inc. (OTC: GOHE) this morning announced that it has appointed Stormy Simon as its new strategy officer and board member. Per the update, Simon spent 15 years with e-commerce giant Overstock.com (NASDAQ: OSTK) prior to joining Global Payout, guiding the company through the early stages of its development as it emerged as a nationally recognized e-commerce leader. In July 2016, she made the decision to part ways with Overstock.com to begin exploration into the emerging cannabis market. “After a couple years of self-education within the cannabis industry, including the ancillary businesses that are emerging to support it, I…

Continue Reading

TuesdayJul 31, 2018 10:28 am

CannabisNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Enters Definitive Agreement to Acquire Canna Farms Ltd.

Globally licensed cannabis company ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced its entrance into a definitive agreement to acquire 100% of the issued and outstanding share capital of Canna Farms Limited, a premium cannabis company in British Columbia. The acquisition enables the two complementary businesses to leverage their strengths prior to the opening of the Canadian adult-use market in the fall. The transaction value of approximately $133 million will be comprised of $22 million in cash and 92.5 million ABcann shares. The shares will be released from escrow in six month increments over a total of 30…

Continue Reading

TuesdayJul 31, 2018 9:55 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Definitive Agreement with Hill Street Beverage Company, Inc. (TSXV: BEER)

Drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP), together with Hill Street Beverage Company (TSXV: BEER), this morning announced that the companies have signed a definitive agreement to license Lexaria's DehydraTECH™ for five years on a semi-exclusive basis to produce a line of cannabis-infused alcohol-free beverages to be distributed in Canada following regulatory approval. The purchase price shall be partially paid to Lexaria in common shares in the capital of Hill Street totaling $56,250, which is equal to 419,982 common shares. The issuance of the shares is subject to regulatory approval. "Hill Street's award-winning and great-tasting wines and…

Continue Reading